天津医药

天津医药 ›› 2020, Vol. 48 ›› Issue (7): 596-598.doi: 10.11958/20200588

• 新冠专题 • 上一篇    下一篇

新型冠状病毒肺炎患者血常规及淋巴细胞亚群的变化特点

朱义朗1 ，徐元宏2 ，汪小五1 ，李梅1 ，高勇1△   

  1. 阜阳市第二人民医院检验科（邮编 236000）；2 安徽医科大学第一附属医院检验科
  • 收稿日期:2020-03-20 修回日期:2020-04-28 出版日期:2020-07-15 发布日期:2020-07-16
  • 作者简介:朱义朗（1972），男，本科，副主任技师，主要从事临床微生物检验研究

Changes of blood routine examination and lymphocyte subsets in patients with COVID-19

ZHU Yi-lang1 , XU Yuan-hong2 ,WANG Xiao-wu1 , LI Mei1 , GAO Yong1△   

  1. 1 Department of Clinical Laboratory, Fuyang Second People's Hospital, Fuyang 236000, China; 2 The First Affiliated Hospital of Anhui Medical University
  • Received:2020-03-20 Revised:2020-04-28 Published:2020-07-15 Online:2020-07-16

PDF (PC)

5291

摘要： 目的 探讨新型冠状病毒肺炎（COVID-19）患者血常规及淋巴细胞亚群的变化。方法 选取2020年1 月—2 月在阜阳市第二人民医院收治的确诊 COVID-19 患者 66 例，将同期住院的疑似并最终排除新型冠状病毒 （SARS-CoV-2）感染的56例患者作为对照组。比较2组患者血常规和淋巴细胞亚群水平的差异，Logistic回归分析 COVID-19 患病的血液细胞学影响因素。结果 与对照组相比，COVID-19 组白细胞计数（WBC）、中性粒细胞 （NEU）、淋巴细胞（LYM）、CD4+ T细胞、CD8+ T细胞、B淋巴细胞水平均降低（P＜0.05）。Logistic回归分析显示，CD4+T 细胞水平升高是COVID-19患者的保护因素（OR=0.997，95%CI：0.994~0.999），同时CD4+ T细胞与LYM计数呈正相关 （rs=0.829，P＜0.01）。结论 COVID-19患者外周血T淋巴细胞水平下降，淋巴细胞亚群分析可为临床诊断SARS-CoV-2的感染和治疗提供参考。

关键词: 肺炎, 病毒性；新型冠状病毒肺炎；新型冠状病毒；淋巴细胞；CD4阳性T淋巴细胞；血常规

Abstract: Objective To investigate the changes of blood routine examination and lymphocyte subsets in patients with coronavirus disease 2019 (COVID-19). Methods Sixty-six confirmed COVID-19 patients admitted to Fuyang Second People's Hospital from January to February 2020 were included in this study.Fifty-six patients suspected but ultimately not diagnosed as novel coronavirus (SARS-CoV-2) infection were used as the control group. Changes of blood routine examination and lymphocyte subsets were compared between the two groups. Logistic regression analysis was used for analysing blood cytological factors of COVID-19 patients. Results Compared with the control group, white blood cell (WBC), neutrophils (NEU), lymphocytes (LYM), CD4+ T cells, CD8+ T cells, and B lymphocytes were all reduced in COVID- 19 group (P＜0.05). Logistic regression analysis showed that the higher levels of CD4+ T-lymphocytes were protective factor for SARS-CoV-2 infection (OR=0.997,95%CI:0.994-0.999). Spearman analysis showed that CD4+ T cells and LYM count were positively correlated (rs =0.829, P＜0.01). Conclusion COVID-19 can cause the decrease of peripheral blood T lymphocyte count in patients. T lymphocyte subsets provide relatively reliable reference for clinical diagnosis and treatment of SARS-CoV-2 infection.

Key words: pneumonia, viral, coronavirus disease 2019, SARS-CoV-2, lymphocytes, CD4-positive T-lymphocytes; blood routine items